导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 35.00% | 103/1038 |
| 近一周 | -0.15% | 44/1092 |
| 近一月 | -2.55% | 276/1090 |
| 近一季 | -17.42% | 900/1080 |
| 近半年 | 20.22% | 136/1058 |
| 近一年 | 32.96% | 145/1008 |
| 近两年 | 80.55% | 284/916 |
| 近三年 | 47.92% | 265/826 |
| 成立以来 | 106.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.57% 162/1070 |
80.10% 108/1101 |
- - |
- - |
| 2025 | 14.89% 755/1065 |
1.63% 671/1014 |
2.61% 461/1038 |
13.75% 771/1050 |
-3.15% 610/1065 |
| 2024 | -0.89% 607/1011 |
-0.81% 356/960 |
-4.74% 620/983 |
11.42% 509/991 |
-5.86% 723/1011 |
| 2023 | -7.32% 263/952 |
2.14% 502/880 |
-5.88% 573/895 |
-0.20% 91/915 |
-3.39% 366/952 |
| 2022 | -20.82% 358/867 |
-18.70% 455/773 |
6.86% 417/806 |
-10.36% 268/845 |
1.68% 342/867 |
| 2021 | -6.13% 433/740 |
-7.16% 423/580 |
13.45% 275/659 |
-14.63% 600/704 |
4.40% 250/740 |
| 2020 | 82.04% 84/554 |
4.53% 81/419 |
35.76% 62/466 |
9.99% 253/517 |
16.63% 175/554 |
| 2019 | 73.71% 23/410 |
33.59% 192/1146 |
3.67% 85/1228 |
13.81% 58/390 |
10.21% 155/410 |
| 2018 | -26.02% 163/349 |
- - |
0.78% 57/990 |
-14.31% 935/1000 |
-11.47% 462/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 鹏华优势企业 VS. 东吴新产业精选股票A(580008) |